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Abstract
Neonatal Borna disease virus (BDV) infection of the rat brain is associated with microglial activation
and damage to certain neuronal populations. Since persistent BDV infection of neurons is nonlytic
in vitro, activated microglia have been suggested to be responsible for neuronal cell death in vivo.
However, the mechanisms of activation of microglia in neonatally BDV-infected rat brains remain
unclear. Our previous studies have shown that activation of microglia by BDV in culture requires
the presence of astrocytes as neither the virus nor BDV-infected neurons alone activate microglia.
Here, we evaluated the mechanisms whereby astrocytes can contribute to activation of microglia
in neuron-glia-microglia mixed cultures. We found that persistent infection of neuronal cells leads
to activation of uninfected astrocytes as measured by elevated expression of RANTES. Activation
of astrocytes then produces activation of microglia as evidenced by increased formation of round-
shaped, MHCI-, MHCII- and IL-6-positive microglia cells. Our analysis of possible molecular
mechanisms of activation of astrocytes and/or microglia in culture indicates that the mediators of
activation may be soluble heat-resistant, low molecular weight factors. The findings indicate that
astrocytes may mediate activation of microglia by BDV-infected neurons. The data are consistent
with the hypothesis that microglia activation in the absence of neuronal damage may represent
initial steps in the gradual neurodegeneration observed in brains of neonatally BDV-infected rats.
Background
Borna disease virus (BDV) is a non-segmented, negative-
strand RNA virus that persistently infects the central nerv-
ous system (CNS) and causes behavioral abnormalities in
a broad spectrum of warm-blooded animals [1-3]. Intrac-
ranial inoculation of newborn rats with BDV leads to a
persistent infection of neurons and astrocytes with mini-
mal signs of classical inflammatory cell infiltration (e.g.,
encephalitis and meningitis), but is associated with a pro-
gressive loss of granule cells in the dentate gyrus of the
hippocampus, Purkinje cells in the cerebellum, and
GABA-ergic neurons in the neocortex [4-7].
BDV replicates slowly without inducing lysis of host
cells[1,3,8]. The mechanisms of selective neuronal loss in
neonatally BDV-infected rats remain unclear. Based on a
temporal and regional association between neuronal
damage and microgliosis, previous studies have suggested
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that activated microglia could contribute to BDV-associ-
ated neuropathology [9-11]. As BDV does not infect
microglia in vivo or in vitro[11,12], and since BDV does not
directly activate cultured purified microglia in vitro[12],
dying BDV-infected neurons have been proposed to trig-
ger microgliosis as a secondary response [13].
However, our previous in vitro study has demonstrated
that persistent BDV infection of cortical cultures leads to
activation of microglia in the absence of neural pathology,
suggesting that activation of microglia precedes cell death
[12]. Furthermore, we also found that astrocytes appear to
be indispensible for the activation of microglia by BDV-
infected neurons [12]. The present study sought to evalu-
ate the mechanisms whereby astrocytes may contribute to
BDV-mediated microglia activation. Using the mixed cul-
ture system, we show that non-cytopathic infection of
neurons stimulates astrocytes that in turn are able to acti-
vate microglia. The present findings indicate that astro-
cytes play a key role in mediating activation of microglia
by BDV infection in the absence of overt neuronal toxicity
or direct infection of microglia.
Methods
Reagents
Lipopolysaccharide (LPS) from Escherichia coli 026:B6,
staurosporine, Hoechst 33258, DNase, poly-L-lysine, lam-
inin, rat interferon-α (IFN-α) and fluorescein isothiocy-
anate (FITC)-labeled isolectin I-B4 from Griffonia
simplicifolia seeds (lectin IB4) were obtained from Sigma
Chemical Co. (St. Louis, MO). Recombinant rat IFN-α
was re-suspended in PBS and frozen in aliquots of 2.6 ×
105 units/ml. A diluted stock solution was prepared in PBS
(2.6 × 103  units/ml). Mouse anti-rat CD11b/c (clone
OX42) monoclonal antibody was purchased from BD
Biosciences (San Diego, CA). Rabbit anti-ionized calcium
binding adapter molecule 1 (Iba1) antibody was obtained
from Wako Chemicals USA (Richmond, VA). Goat poly-
lonal anti IL-6 antibody was from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA). Chicken anti-microtubule
associated protein 2 (MAP2) polyclonal antibody, rabbit
anti-glial fibrillary acidic protein (GFAP), anti-ED1 MAB
and the secondary antibodies carbocyanin (Cy) 3, Cy 5 or
fluorescein isothiocyanate (FITC)-conjugated donkey
anti-mouse, anti-rabbit and anti-chicken IgG antibodies
were obtained from Chemicon (Temecula, CA). Mono-
clonal antibody directed against BDV protein N (Bo18)
was a generous gift by Dr Juergen Richt, National Animal
Disease Center, 2300 Dayton Avenue, Ames, IA [14]. Dul-
becco's modified Eagle medium (DMEM) with high glu-
cose (4,500 mg/l), DMEM/F12 (1:1) nutritional
supplemented media, Neurobasal-A medium, serum-free
B-27 supplement (NBM), heat-inactivated horse serum
(HS), HEPES buffer solution (HBS), Hank's balanced salt
solution (HBSS), L-glutamine solution, penicillin-strepto-
mycin solution (P/S, 50 U/50 μg per ml), trypsin (0.25%)-
EDTA (1 mM) and trypan blue were purchased from Inv-
itrogen/GIBCO-BRL (Carlsbad, CA). Certified heat-inacti-
vated fetal bovine serum (FBS) was obtained from
Hyclone (Logan, UT). LPS stocks of 1 mg/ml were pre-
pared in DMEM.
Virus stock preparation and titration
Virus stock was prepared from human oligodendroglia
cells (kindly provided by Dr G. Pauli, Institut für Virolo-
gie, Freie Universität Berlin, Germany) persistently
infected with BDV strain He/80 as described previously
[12]. Briefly, confluent 175-cm2  culture flasks were
washed with 20 mM HEPES (pH 7.4) and incubated with
20 ml of 20 mM HEPES containing 250 mM MgCl2 and
1% FBS for 1.5 hours at 37°C. Subsequently, supernatants
were harvested and centrifuged twice at 2500 × g for 15
minutes to remove cell debris. Virus particles were con-
centrated by ultra-centrifugation for 1 hour at 20°C at
80,000 × g onto a 20% sucrose cushion containing 20 mM
HEPES and 1% FBS. Virus-containing pellets were resus-
pended in PBS to approximately 107 focus-forming units/
ml. Determination of viral titers was carried out on C6 rat
glioma cells (ATCC, Manassas, VA) by an immunofocus
assay with the monoclonal anti-BDV antibody Bo18 as
described previously [12]. Mock stock was prepared from
uninfected Oligo cells as described above for BDV stock.
Cell culture
Pure microglia and astroglia cultures
All experiments were performed with adherence to the
National Institutes of Health guidelines on the use of
experimental animals and the protocols approved by the
Johns Hopkins Medical Institutions' Research and Animal
Care Committee. To prepare mixed glial cultures, cerebral
cortices from 1–3-day-old Fisher344 rats (Harlan, Indian-
apolis, IN) were surgically removed and placed in cold
DMEM, the meninges carefully separated, and cortices
minced and dissociated with trypsin-EDTA at 37°C for 15
minutes. After tituration with DNase (3 μg/ml), the mixed
glial cell suspension from 2 brains was plated in a poly-L-
lysine coated 75-cm2  vented cell culture flask with
DMEM/F12 medium supplemented with 10% FBS and
1% (v/v) P/S and grown in a humidified 5% CO2 incuba-
tor at 37°C. On days 14 to 21 in vitro, microglia were
detached using an orbital shaker (150 rpm, 7 h, 37°C),
centrifuged (150 × g, 15 minutes), and microglia number
and viability were assessed by trypan blue exclusion.
Depending on the particular experimental protocol (see
below), microglia were plated in either 96-well cell cul-
ture plates, 24-well cell culture plates, or cell culture
inserts in DMEM supplemented with 10% FBS and 1% (v/
v) P/S, and placed in a humidified 5% CO2 incubator at
37°C.Journal of Neuroinflammation 2008, 5:50 http://www.jneuroinflammation.com/content/5/1/50
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To prepare pure astroglia, mixed glial cultures were
washed every other day with fresh medium to remove
loosely attached microglial cells and inhibit microglia
growth. After 2–3 weeks in culture, glial cultures were pas-
saged (1:4 split ratio) using trypsin (0.25%), and allowed
to form a confluent monolayer for 3 to 7 days. This mon-
olayer consisted of ~90–97% astrocytes and was used for
infection with BDV. Infected cells were fed every week and
passaged no more then 3 times or 2 months post infec-
tion.
Cortical neuron-rich cultures
Neuron-rich cultures were prepared from cortices of
Fisher344 rats (Harlan, Indianapolis, IN) at embryonic
days 19–20 using standard techniques [12,15]. Briefly,
meninges-free cortices were isolated, trypsinized and
mechanically dissociated by passing through fire-polished
Pasteur pipettes. Washed cells were plated onto poly-L-
lysine (0.05 mg/ml) and laminin (0.1 mg/ml)-coated tis-
sue culture coverslips (200,000 cells/cm2) in Neurobasal-
A medium with L-glutamine, B27 and P/S supplements
(complete neurobasal medium, NBM). On day 2 in vitro,
cells were infected with BDV or mock stocks diluted with
fresh media with a multiplicity of infection (m.o.i.) of
0.02. Medium was partially (50%) replaced every 4th day
thereafter. The composition of major cell types in the cul-
tures was estimated by visual counting of cells immunos-
tained with anti-MAP2 (neuron) or anti-GFAP
(astrocytes) antibodies. Neuron-rich cultures contained >
95% neurons and < 4% glia.
Cortical mixed neuron/glia cultures
For preparation of mixed neuron and glia cultures, corti-
ces from E15–E16 embryos (Fisher344 rats) were used as
described previously [12,16]. Dissociated cells (350,000
cells/cm2) were cultured in DMEM/F12 supplemented
with 5% FBS, 5% HS and 1% P/S (v/v) and otherwise
treated as described above for neuron-rich cultures. Typi-
cal mixed neuron-glia cultures contained more astrocytes
than neurons, astrocyte:neuron counts were split 2:3.
Neuronal cell lines
Rat neuronal cell line, derived from mesencephalus (AF5,
Sprague-Dawley rat origin [17,18]) was generously pro-
vided by Dr. W.J. Freed (National Institute on Drug Abuse,
Baltimore, MD); medullary thyroid carcinoma CA-cell
line (CA77) [19] was generously provided by Dr. A.F.
Russo (University of Iowa, Iowa City, IA). All cells were
cultured in DMEM/F12 medium supplemented with 10%
FBS and passaged every 3–10 days, upon reaching conflu-
ence. Cells were infected at m.o.i. of 0.05. Persistently
BDV- or mock-infected cells were evaluated as sister cul-
tures of the same passage, passaged in parallel, and used
for experiments at passages 5–10 p.i.
Preparation of conditioned medium
All experiments were performed on sister cultures infected
with either mock or BDV. Conditioned media from mock/
BDV cells were purified from cell derived particles by cen-
trifugation (5,000 g, 20 min, +4°C) and filtration through
a 0.22 μm filter and stored at +4°C for up to 48 h. Half of
the medium was incubated at 65°C in a water bath for 2
h to inactivate the virus. For some experiments, the
medium was boiled in a microwave (2 kW, 30 s). For co-
culture experiments, conditioned medium was mixed 1:1
with fresh media. Successful complete heat inactivation of
the virus was confirmed by an immunofocus virus titra-
tion assay.
Cytokine/chemokine ELISA
Assays were performed on stored frozen (-70°C) superna-
tant samples obtained at time points indicated in the text.
Cytokines IL1-β, IL6, IL10, TNF-α, and RANTES were
determined using a sandwich ELISA (R&D Systems, Min-
neapolis, MN). Twenty five μl of media from a microglia
culture were incubated with 50 μl of assay diluent in the
assay plate for 2 h at room temperature. After washing
away any unbound substances, horseradish peroxidase-
linked polyclonal anti-cytokine antibody was added to
the wells. Following the addition of the peroxidase sub-
strate solution, the enzyme reactive color product was
detected by a microplate reader set to 450 nm with wave-
length correction set to 540 nm.
Multiplex cytokine assay
The rat 23 cytokines/chemokines LINCOplex (IL-1a, IL-
1β, IL-2, IL-4, IL-5, IL-6 IL-10, IL-18, GM-CSF, GRO/KC,
IFN-gamma, MCP-1, TNF-α, IL-9, IL-13, IL-17, Eotaxin, G-
CSF, Leptin, MIP-1α, IP-10, RANTES, VEGF) from Milli-
pore was used. The LINCOplex assay was conducted as per
the manufacturer's instructions (Linco Research, Inc., St.
Charles, MO). In brief, the assay is based on conventional
sandwich assay technology. The antibody specific to each
cytokine is covalently coupled to Luminex microspheres,
with each antibody coupled to a different microsphere
uniquely labeled with a fluorescent dye. The microspheres
are incubated with standards, controls, and samples (25
μl) in a 96-well microtiter filter plate for 14 h at 4°C. After
incubation, the plate is washed to remove excess reagents,
and detection antibody, in the form of a mixture contain-
ing each of the 24 antibodies, is added. After 2-hr incuba-
tion at room temperature, streptavidin-phycoerythrin is
added for an additional 30 min. After a final wash step,
the beads are resuspended in buffer and read on the
Luminex 100 instrument to determine the concentration
of the cytokines of interest.
ATP quantification
Adenosine 5'-triphosphate (ATP) determinations were
performed using a bioluminescent luciferase ATP assay kitJournal of Neuroinflammation 2008, 5:50 http://www.jneuroinflammation.com/content/5/1/50
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(Sigma Aldrich) according to manufactures recommenda-
tions as previously described [20]. Media samples were
collected from confluent mock- or persistent or acutely
infected cultures grown in 6-well dishes for 7 days. Cell
homogenates were prepared from the PBS-washed cul-
tures by scrapping the cells off the bottom of the dishes
with a cell scraper and spinning at 4°C degrees at 3000 g
for 5 minutes to remove excess of PBS. Cell culture media
and pellet samples were stored at -80°C in 200 μl aliq-
uots.
IFN-α biological activity assay
Activity of type I interferon (IFN-α) in conditioned culture
media was evaluated by its ability to inhibit replication of
vesicular stomatitis virus (VSV) in C6 cells. A recombinant
VSV expressing the green fluorescent protein (GFP) [21]
was a generous gift from John Hiscott, PhD, McGill Uni-
versity, Montreal, Canada, Dr Peter Collins and Dr Ulla
Buchholz, NIH, Bethesda, MD, USA. C6 cells were main-
tained in DMEM +9% FBS; 1.25 × 105 cells were seeded
into 24 wells. Sixteen hours later, cells were pre-treated
with samples of mock or BDV-conditioned media col-
lected as described for the ATP assay and diluted 4-fold in
DMEM (300 μl of media per well). Controls wells were
pre-treated with 0, 10, 100 or 1000 units of rat IFN-α. 24
hours later, C6 cells were challenged each with 2000 PFU
of VSV-GFP (stock 2.5 × 108 PFU/ml; multiplicity of infec-
tion 0.005). Nine hours later, the number of cells express-
ing GFP was evaluated by fluorescence microscopy. To
this end, 22–30 visual fields were evaluated using ×10
objective to view the entire outer area of a well of a 24-well
plate under a fluorescent microscope (Nikon Eclipse
TE2000-U). Individual GFP-positive cells and numbers of
foci (defined as a group of 4 and more GFP-positive cells)
were scored.
Immunocytochemistry
Co-cultures were washed two times with PBS and then
fixed for 25 minutes with either phosphate buffered saline
(PBS) plus 4% (w/v) paraformaldehyde at room tempera-
ture. After permeabilisation with 0.1% Triton X-100
(Sigma), cultures were blocked for 2 h in PBS with 2%
donkey serum (Chemicon) and further incubated with
primary antibody mixtures overnight at 4°C in blocking
solution. After washing extensively, the cultures were
incubated with secondary antibodies in blocking solution
for 1 hour at room temperature. Antibodies against the
following proteins were used: MAP2 (1:1000 dilution) as
neuronal marker; GFAP (1:800) as astrocyte marker; ED1
(1:100), CD11b/c (1:50) and Iba1 (1:800) as microglia
markers; activated caspase 3 (1:200) as apoptotic marker;
cytokine IL-6 (1:500) and MHC I (1:100), MHC II (1:100)
as pro-inflammatory markers; and anti-BDV N (1:50).
Immunostaining without primary antibodies or staining
of uninfected cultures were used as negative controls.
Microglia were also stained with lectin IB4 as described
previously [12]. Following mounting with Gel/Mount
medium (Electron Microscopy Sciences, Hatfield, PA), the
samples were allowed to dry in the dark and were viewed
using a 40× objective lens on a LSM-5 confocal micro-
scope from Carl Zeiss (Melville, NY) or Nikon Eclipse
E400 equipped with the digital camera CoolSnap™ ES
(Roper Scientific Production). Digital images of the cells
were captured and processed by using standard software
supplied with the microscopes. All sister culture samples
were stained in parallel and imaged under the same
parameters (exposure time, digital gain, magnification) to
allow quantitative comparison of digital images. Digital
intensity of staining was analyzed in at least 10 micro-
scopic fields per sample.
Semi-automated counting of activated microglia
Activated microglia were stained with lectin-FITC and
imaged on a Nikon-Eclipse microscope to determine acti-
vated microglia numbers. The bright lectin-labeled round-
shaped microglia had remarkably consistent size and
shape appearance, and represented a subpopulation of
activated, strongly ED1 and CD11b-positive microglia
cells (see text). Lectin weakly stained resting ramified 'rest-
ing' microglia, but these cells were barely distinguished
from a weakly lectin-positive background that was likely
due to stained astrocytes. Therefore, round-shaped lectin-
positive cells can be easily counted automatically. Round
microglia cells are considered to represent the end-stage of
microglia activation [12]. In addition, uniformly-sized
round cells are easy to count by an unbiased observer.
This approach helps exclude multiple intermediate spe-
cies of microglia that seem to be at various stages of acti-
vation. Digital images were coded and counted semi-
automatically using the "threshold" and "count particles"
tools of the ImageJ software (NIH, Bethesda, MD). The
threshold was set to label only round-shaped microglia
cells, and the particles detection parameters were chosen
to minimize counting of artifacts (i.e. bright objects less or
significantly larger than a typical microglial cell). At least
10 random fields were evaluated for each culture.
Statistical analysis
All experimental results are presented as mean ± SEM of
BDV/mock ratios, with each value being obtained from a
pair of sister cultures treated with media collected from
BDV- or mock-infected cells, or BDV and mock-treated
virus preparations. Experiments were repeated at least
three times. Each experiment included two-five independ-
ent sister cultures, with each culture being plated in at
least two-five wells per treatment condition. The data was
analyzed with paired t-test for comparisons between two
related groups (mock and BDV sister cultures). P value
below 0.05 was used as the indication of significant differ-
ences.Journal of Neuroinflammation 2008, 5:50 http://www.jneuroinflammation.com/content/5/1/50
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Results
Round-shaped microglia formation represents microglia 
activation in BDV-infected brain cultures
To investigate how BDV infection of neurons could acti-
vate microglia, we used neuron-glia-microglia cultures, in
which BDV infection is manifested by high numbers of
'round' microglia cells that are morphologically different
from resting 'ramified' microglia [12]. To find an optimal
way of quantifying the microglia response to infection, we
compared four markers of rat microglia (Figure 1a and
1B). In infected mixed cultures, IB4-lectin labeled only
round microglia, whereas Iba1, CD11b, and to a lesser
extent, monocyte-specific ED1 staining was present in
both 'round' and 'ramified' microglia, indicating that
'round' microglia and 'ramified' microglia are two sub-
populations of the same cell type (Figure 1A and 1B).
Individual microglial cells in mock and BDV cultures did
not differ in the distribution of the ED1, CD11b, Iba1 and
IB4 staining, however BDV cultures contained significantly
more round shaped microglia cells, consistent with our
previous observations [12]. In addition, strong labeling
for MHC-I and II (data not shown), and a pro-inflamma-
tory cytokine, IL-6 (Figure 1C) indicated that round-
shaped lectin-positive microglia were functionally acti-
vated. Thus, BDV-induced activation of microglia in
mixed cultures can be reliably evaluated by assessing
numbers of lectin-positive round-shaped cells.
Microglia are activated by BDV-infected astrocytes
Our previous studies have demonstrated that the presence
of astrocytes in mixed cultures appeared to be an impor-
tant factor for BDV-associated activation of microglia
[12]. Specifically, in contrast to mixed neuron/astroglia/
microglia cultures, co-culture of pure BDV-infected neu-
rons and pure microglia does not produce microglia acti-
vation. This data is in line with prior studies that have
shown that astrocytes play a role in activating microglia
during different neuroinflammatory and neurodegenera-
tive processes [22,23].
Unlike microglia, astrocytes are susceptible to BDV infec-
tion and both neurons and astrocytes constitute BDV
hosts in mixed neuron/microglia/glia cultures (Figure 2A)
[11,24]. Therefore, one mechanism whereby astrocytes
might activate microglia in mixed cultures is through BDV
infection of astrocytes themselves. To evaluate this possi-
bility, we seeded mixed neuron/astroglia/microglia cells
over mock- or BDV-infected astrocytes and found that
direct contact with BDV-infected astrocytes produced 1.97
± 0.63 (mean ± S.D.) times more round microglia cells as
compared to mock-infected astrocytes (Figure 2B).
To evaluate if direct contact between microglia and
infected astrocytes is required, we compared microglia
activation in mixed cultures either infected with BDV or
exposed to conditioned medium from mock- or BDV-
infected astrocyte cultures (Figure 2B). Conditioned
medium from BDV-infected astrocytes produced a strong
microglia activation that was even greater compared to
that found in mixed cultures directly infected with the
virus (Figure 2B gray column versus white column). Fur-
thermore, to rule out a contribution of BDV infection
transferred from pure astrocytes to mixed cultures, condi-
tioned media were pre-treated with heat (30 min, 65°C).
Heat inactivation did not inhibit microglia activation
(Figure 2B black column versus gray column). In a sepa-
rate experiment, large cell-derived components precipi-
tated by centrifugation of BDV-conditioned medium were
found not to induce microglia activation (data not
shown). Taken together, the presented data suggest that
microglia might be activated by small soluble heat-resist-
ant substance(s) released by BDV-infected astrocytes.
Activation of astrocytes by BDV infection
Activated astrocytes have been demonstrated to actively
participate in promoting neuroinflammation [e.g., [25]].
To evaluate activation of astrocytes by BDV infection, we
assessed the profiles of cytokine/chemokine protein
expression in BDV-infected mixed neuron/glia/microglia
and BDV-infected purified astrocyte cultures using the
multiplex assay, LINCOplex. Among 23 analytes, only
RANTES was significantly up-regulated in both culture
preparations, providing a molecular marker of BDV-
induced activation of astrocytes (Figure 3).
However, in contrast to pronounced BDV infection of
astrocytes in culture (Figure 2A), astrocytes in vivo largely
avoid BDV infection during the first month after inocula-
tion [9-11]. Since microgliosis and astrogliosis are evident
in the brain one week after inoculation with BDV [26,27],
direct BDV infection of astrocytes is unlikely a factor in
mediating microglia activation in vivo. In order to evaluate
whether BDV-infected neurons can activate astrocytes
without infection of the latter, we exposed primary unin-
fected astrocytes to heat-inactivated 2-day conditioned
medium from mock- or persistently BDV-infected AF5
neuronal cells. AF5 neuronal cells grown in the same
media as astrocytes were chosen for this experiment
because our pilot experiments had shown that serum-free
medium from primary purified neurons was toxic to
microglia and astrocytes. Treatment of astrocytes with
media collected from BDV-infected neurons induced a 4.7
fold higher up-regulation of RANTES as compared to
astrocytes treated with media from mock-infected neu-
rons (Figure 4). This indirect activation of astrocytes, how-
ever, was lower than the 33-fold increase in RANTES
expression (BDV vs. mock) by directly infected astrocytes
and the 124-fold increase by infected mixed neurons/
astrocyte/microglia cultures (Figure 4). Taken together,
our findings demonstrate that heat-inactivated condi-Journal of Neuroinflammation 2008, 5:50 http://www.jneuroinflammation.com/content/5/1/50
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BDV infection induces formation of round 'activated' microglia in mixed cultures Figure 1
BDV infection induces formation of round 'activated' microglia in mixed cultures. Mixed neuron-glia-microglia cul-
tures were BDV- or mock-infected on the 1st day in vitro (DIV), fixed on the 10th DIV and labeled with microglia-specific 
markers Iba1, CD11b, ED1 and lectin, or with astrocyte-specific marker GFAP, or a pro-inflammatory cytokine, IL-6. A – Co-
localization of CD11b, lectin and Iba1 in round microglia (white arrows) but not in resting CD11b+ microglia (yellow arrows). 
B – Co-localization of ED1, lectin, and Iba1 in round microglia (white arrows) but not in resting ED1+ microglia (yellow 
arrows). C – Positive staining for IL-6 in round microglia (white arrows) but not astrocytes. Scale bar – 100 μm. The quantita-
tive analysis of round microglia counts is shown in Figure 2A (the first column).Journal of Neuroinflammation 2008, 5:50 http://www.jneuroinflammation.com/content/5/1/50
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Figure 2 (see legend on next page)
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tioned medium from BDV-infected neurons induced acti-
vation of uninfected astrocytes in vitro.
Astrocytes mediate activation of microglia by infected 
neurons
To investigate if astrocytes activated by BDV-infected neu-
rons could in turn stimulate microglia activation, mixed
cultures were treated with conditioned media from pure
astrocytes that were pre-treated with conditioned media
collected from mock- or BDV-infected neuronal AF5 cells
(see Figure 5 for the experiment design). Compared to
mixed cultures treated with media from astrocytes per-
treated with media from mock-infected neurons, we
found a 3.9-fold increase in the number of round micro-
glia cells in mixed cultures treated with conditioned
media collected from astrocytes pre-treated with media
from BDV-infected neuronal cells (BDV-AF5-astrocyte-
treated mixed cultures (Figure 6A). To confirm functional
activation of round shaped microglia, we stimulated
mixed cultures with LPS and observed a significantly
larger release of TNF-α and IL1-β by BDV-AF5-astrocyte
treated cultures vs. mock-AF5-astrocyte treated mixed cul-
tures (Figure 6B). We also found that astrocyte activation
was not limited to the AF5 neuronal cell line and was also
observed after treatment of astrocytes with media col-
lected from the BDV-infected CA77 neuronal cell line or
from infected primary cortical neurons (Figure 6C). Fur-
thermore, we used mock or BDV-infected primary cortical
neurons at 10 d.p.i. in a similar experiment. Since media
for primary astrocytes and primary neurons are incompat-
ible, primary neurons were switched to serum-containing
media one day before the experiment. Such conditioned
media from primary BDV-infected neurons activated
astrocytes as evidenced by their (i.e., astrocytes) ability to
produce a 2.54 ± 0.86-fold increase in numbers of round
microglia cells in mixed cultures compared to mixed cul-
tures treated with media collected from astrocytes pre-
treated with media from mock-infected primary neurons.
Soluble factors that may mediate activation of astrocytes 
and microglia
Our present experiments clearly demonstrate that soluble
factors released by BDV-infected neurons or activated
astrocytes likely play a role in cell-to-cell communications
in culture. Thus, we performed an initial characterization
of potential mediators of neuron-astrocyte-microglia
interactions.
Activation of astrocytes by BDV proteins
Astrocytes can be activated by viral proteins and other
pathogens (e.g., HIV-encoded Tat protein or LPS [28,29].)
As conditioned medium from BDV-infected neurons is
infectious and since this infectivity is abolished by heat-
inactivation (data not shown), BDV proteins released by
infected neurons could potentially contribute to activat-
ing astrocytes. To investigate if BDV proteins can activate
astrocytes, we used increasing amounts of virus stock to
infect mixed neuron/astroglia/cultures (data not shown).
4 days after infection, virus spread to the majority of neu-
rons and the percentages of infected neurons were compa-
rable between wells exposed to 1, 5 or 20 μL of the virus
stock per 1 mL of media (data not shown). In contrast, the
number of round-shaped microglia cells proportionally
rose with the increase in the concentration of the stock
used, suggesting that despite the equivalent infectivity of
neurons, more virus proteins delivered with virus stock
induced more activation of microglia. Furthermore, to
evaluate if astrocytes can be directly activated by BDV pro-
teins without being productively infected by BDV, BDV or
mock stocks were exposed to UV light for 40 min and the
inactivated mock/BDV stocks were applied to astroglia
cultures (no astrocyte infection was observed, data not
shown). Conditioned media collected from treated astro-
cytes were able to induce microglia activation in mixed
neuron/astroglia/microglia cultures (6.3 ± 0.9 vs. 11.8 ±
2.6 round microglia per field, mock vs. BDV treatment).
Moreover, treatment of mixed cultures with LPS led to
secretion of a greater amount of TNF-α upon exposure to
media collected from astrocytes treated with inactivated
BDV particles compared to mock stocks (data not shown).
Microglia are activated by conditioned media from BDV-infected astrocytes Figure 2 (see previous page)
Microglia are activated by conditioned media from BDV-infected astrocytes. A – Mixed cultures were mock-or 
BDV-infected and stained with GFAP and BDV antibodies and lectin at 14 days p.i. Note that the astrocyte monolayer is a 
dominating cell surface in culture, providing bedding for microglia and neurons. Infected neurons can be identified as bright red 
round cells (white arrow). Many astrocytes are infected (yellow arrows). Note the absence of BDV infection of microglia 
(green stain). Scale bar – 50 μm. B – The numbers of round-shape activated microglia in 14 DIV mixed cultures infected on the 
2nd DIV (white column); exposed to 2-day old conditioned media collected from BDV-infected astrocytes on the 10th DIV 
(gray column), or exposed to heat-inactivated media collected from BDV-infected astrocytes (black column). Each bar repre-
sents mean ± SEM (n = 5–12 experiments). The data are presented as the number of round microglia cells in BDV versus 
mock-treated sister mixed cultures. The results of the paired t-test on two populations (mock vs. mean) are shown as asterisks 
(*p < 0.05; **p < 0.005) Scale bar – 50 μmJournal of Neuroinflammation 2008, 5:50 http://www.jneuroinflammation.com/content/5/1/50
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Thus, our results indicate that BDV proteins could medi-
ate activation of astrocytes in culture.
Soluble factors that activate astocytes or microglia
Several soluble factors released by astrocytes can induce
microglia activation in culture, including cytokines and
chemokines (e.g., RANTES, M-CSF, IL-6) [21]. We found
no significant alterations in levels of 23 soluble factors in
culture media from astrocytes pre-treated with media
from BDV-infected AF5 cells using a 23 cytokine/chemok-
ine multiplex assay (data not shown). Finally, heat-inacti-
vation of culture media collected from BDV-infected
astrocytes had no effect on the ability of the media to acti-
vate microglia in mixed cultures (Figure 2B, black column
versus gray column). This result suggests that putative sol-
uble factors that mediate activation of microglia are heat-
resistant soluble factors. Despite that fact that this heat-
resistance requirement seems to exclude the majority of
cytokines or chemokines, inteferons of type I could still
remain functional after heat treatment [30]. Although
recent studies have demonstrated that genomic RNAs
from some negative-strand RNA viruses, including BDV,
do not trigger interferon induction [31,32], we evaluated
the effects of media collected from AF5 (BDV or mock)
cells on replication of VSV that is highly susceptible to the
antiviral action of interferon (IFN). As expected, our pos-
The effects of BDV infection on expression of cytokines and chemokines in astrocyte or mixed cultures Figure 3
The effects of BDV infection on expression of cytokines and chemokines in astrocyte or mixed cultures. Super-
natants were analysed for cytokine/chemokine protein contents using the rat 23 cytokines/chemokines LINCOplex assay. Lev-
els of cytokines and chemokines in media samples from BDV-infected cultures normalized to the values in obtained from 
respective mock-infected sister cultures. Media samples were collected from n = 6 mixed astrocyte/neuron/microglia cultures 
at 12–14 d.p.i. and from n = 4 persistently infected astrocyte cultures at 7–10 days after passage.
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itive control experiments demonstrated that pre-treat-
ment of rat C6 astrocytes with rat IFN-α at the doses of 10,
100 or 1000 units/ml dose-dependently inhibited replica-
tion of VSV-GFP, as evidenced a dramatic decline in the
number of GFP-positive cells. In contrast, media collected
from mock- or BDV-infected AF5 cells had no significant
effects on replication of VSV, leading to lysis of C6 cells,
similar to VSV-infected C6 cells left untreated (data not
shown).
Certain nucleotides, notably ATP, have been shown to
activate astrocytes or microglia [33-36]. We used a biolu-
minescent luciferase assay to measure ATP concentration
in media samples collected from BDV- or mock-infected
neuronal cell lines. Neither acute nor persistent BDV
infection of AF5 neuronal cells altered ATP concentrations
in culture media: AF5 mock – 1.12 ± 1.61 nM vs. AF5 BDV
– 1.27 ± 1.77 nM (n = 13); CA77 mock – 1.00 ± 0.87 nM
vs. CA77 BDV – 1.09 ± 1.20 nM (n = 6). Similar data were
obtained for media from primary astrocytes, primary
mixed cells exposed to media from astrocytes, primary
mixed cells exposed to media from primary astrocytes pre-
treated with media from AF5 cells, or primary astrocytes
exposed to media from AF5 neuronal cells (data not
shown). Furthermore, we found that neither persistent
nor acute BDV infection changed intracellular concentra-
tions of ATP as measured in cell pellets from AF5, CA77 or
PC12 cells (data not shown). As expected, intracellular
concentrations of ATP in various neuronal cells were
approximately 10–100-fold higher than concentrations of
ATP in corresponding culture media.
Discussion
The present study demonstrates that astrocytes play a key
role in activating microglia by BDV infection. Our data
suggest the following sequence of events that mediate acti-
vation of microglia in the course of BDV infection: BDV-
infected neurons may release soluble heat-resistant mole-
cules or virus-associated particles and/or viral proteins
that can activate uninfected astrocytes as evidenced by
expression of RANTES. Activated astrocytes in turn are
able to stimulate microglia that acquire a round shape,
express MHC I, MHC II and IL-6, and display increased
secretion of TNF-α and IL1-β upon LPS priming. Activated
astrocytes may secrete soluble heat-resistant low molecu-
lar weight factors that activate microglia.
Intracranial inoculation of BDV into newborn rats is asso-
ciated with a gradual loss of a) granule cells of the dentate
gyrus of the hippocampus, b) Purkinje cells in the cerebel-
lum and c) GABA-ergic neurons in the cortex and striatum
[1,7,13]. However, the mechanism of BDV-associated
neuronal loss is poorly understood as, unlike neurotropic
lytic virus infections (e.g., cytomegalovirus, Semliki forest
virus), BDV does not induce any apparent toxicity to neu-
rons that are the primary host cells in the CNS [8,12].
Given the overall strong temporal and regional associa-
tion of neurodegeneration and microgliosis in BDV-
infected rat brains, it is tempting to speculate that micro-
glia activation results from BDV-induced cell death. Nota-
bly, reactive gliosis is a universal response of the innate
immune system to brain pathology[37]. The exact func-
tions of this phenomenon are not completely understood
but the available data seem to indicate that reactive gliosis
may support injured neurons and/or eliminate terminally
damaged cells [38,39]. BDV infection, however, is non-
lytic in culture, suggesting that activation of microglia by
BDV infection is unlikely initiated by cell damage.
Astrocytes are activated by BDV and conditioned media  from BDV-infected neurons Figure 4
Astrocytes are activated by BDV and conditioned 
media from BDV-infected neurons. Measurement by 
ELISA and multiplex of the release of RANTES by BDV-
infected mixed cultures (white bar), persistently BDV-
infected pure astrocytes (gray bar) or after exposing primary 
uninfected astrocytes to media collected from BDV-infected 
neuronal cells (dark gray bar). Media were collected at 10–14 
d.p.i. for mixed cultures, at 7–10 days after passage for per-
sistently infected astrocytes, and at 2–4 days after AF5-media 
treatment for astrocyte cultures. Each bar shows mean ± 
SEM normalized to values obtained from respective mock-
treated sister cultures. Dots indicate single data values for 
each experiment. The results of the paired t-test on two 
populations (mock vs. mean): *p < 0.05
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Our previous studies have demonstrated that neither
exposure of microglia to the virus nor exposure of micro-
glia to BDV-infected neurons leads to activation of micro-
glia. It is the presence of astrocytes in mixed cultures that
is required for microglia to be activated [12]. This result is
consistent with prior reports that have demonstrated the
importance of astrocytes for activation of microglia. For
example, astrocytes have been found to enhance LPS-
induced nitric oxide production by microglial cells [39],
mediate microglia activation by trimethyltin [40], or
modulate microglia signaling pathways during neuroin-
flammation [41]. Until recently, most studies interpreted
the timing of activation of astrocytes to the effect that they
rather play a secondary role in the initiation of events.
However, there is a growing body of evidence that sug-
gests an initiating role of astrocytes in neuroinflammation
[38,42]. We believe that persistent BDV infection repre-
sents another example when astrocytes play a crucial role
in triggering the innate immune response in the CNS and
provides a valuable model for studying the molecular
mechanisms of cell-to-cell communications in the context
of chronic neuroinflammation and resultant neurobehav-
ioral abnormalities.
Our findings further indicate that direct cell contacts
between neurons and astrocytes are not required for acti-
vating microglia and that soluble factors secreted by neu-
rons and astrocytes appear responsible for microglia
activation. Since uninfected astrocytes need to be acti-
vated first to mediate ensuing activation of microglia, we
explored what factors could be involved in this process.
Factors produced by neurons in response to infection or
injury include viral proteins and various chemokines and
cytokines [43]. Based on the UV inactivation experiments
as well as the enhanced astrocyte activation using increas-
ing amount of virus stock, we speculate that certain viral
BDV proteins may mediate activation of astrocytes. The
data is in line with the observations that Tat or gp120 acti-
vate astrocytes by destabilizing intracellular Ca2+, subse-
quently leading to release of RANTES and IL-6 [28,44]. It
should be pointed out that both mock and BDV virus
stocks were prepared using the standard protocol [12] and
contained virus particles as well as cellular and viral pro-
tein contaminants. Thus, activation of astrocytes could be
due to virus related components such as particle-associ-
ated and free viral proteins. In contrast, a contribution of
cellular material unrelated to BDV appears unlikely since
mock and BDV stocks were purified and used under the
identical conditions throughout the study. We found that
treatment of primary astrocytes with media collected from
BDV-infected neurons led to up-regulation of RANTES.
These results are consistent with previous studies that
demonstrated an up-regulation of IP-10 and RANTES in
the brains of neonatally BDV-infected rats [45,46]. Inter-
estingly, the authors have found that a likely source of
chemokines in the infected brain parenchyma are astro-
cytes, compatible with our hypothesis that astrocytes are
activated by BDV-infected neurons to initiate neuro-
inflammatory cascades in situ as well.
Activated astrocytes produce soluble factors that activate microglia Figure 5
Activated astrocytes produce soluble factors that activate microglia. The experimental design: Two-day old condi-
tioned media collected from sister mock- or BDV-persistently infected neuronal cultures (culture #1: AF5, CA77 or primary 
neurons) were heat-inactivated and transferred to primary astrocytes (culture #2) to induce astrocyte activation. 24 hours 
after transfer of media, activated astrocytes were washed, fresh medium was added and collected one day later. This astrocyte 
conditioned medium was transferred to mixed neuron/astrocyte/microglia (culture #3) to induce microglia activation.
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Activated astrocytes have been shown to produce soluble
factors that are able to activate microglia [22]. What acti-
vates microglia in the course of BDV infection remains
obscure. In a search for possible candidates, we screened
22 soluble cytokines and chemokines using a mulitplex
analysis. Only RANTES was found to be significantly up-
regulated by BDV infection Furthermore, in our prelimi-
nary experiments, MG-CSF failed to induce round micro-
glia formation under the conditions where BDV infection
did (data not shown). Interestingly, heat inactivation of
conditioned media from BDV-infected astrocytes (used as
a positive control of astrocyte activation) had no effects
Astrocytes activated by BDV-infected neurons induce microglia activation in mixed cultures Figure 6
Astrocytes activated by BDV-infected neurons induce microglia activation in mixed cultures. A – Lectin staining 
of round microglia in mixed cultures left either uninfected and untreated (control), or BDV-infected and untreated, or unin-
fected but treated with conditioned media from AF5-activated astrocytes. Scale bar – 50 μm. The quantitative data for AF5-
activated astrocytes are presented in C (column a). B – LPS-induced production of TNF-α and IL-1β by mixed cultures. TNF-α 
and IL-1β were measured by ELISA. Note a significant up-regulation of the cytokines in mixed cultures activated by conditioned 
media from astrocytes pre-treated with media collected from BDV-infected AF5 neuronal cells. Values are given as ratio com-
pared to concentrations measured in mixed cultures exposed to conditioned media from astrocytes pretreated with media 
collected from mock infected AF5 neuronal cells, n = 3–5. C – Activation of microglia in mixed cultures following exposure to 
medium from astrocytes conditioned with medium from different types of infected neuronal cells. Astrocytes can be activated 
by persistently BDV-infected neuronal AF5 cells (a) or CA77 cells (b). Medium from persistently BDV-infected astrocytes (c) as 
well as LPS treatment of mixed cultures (d) were used as positive controls. Conditioned media from different pre-treated 
astrocyte cultures were added to mixed cultures to activate microglia. The results are numbers of round microglia cells in 
BDV-treatments normalized to respective mock-treated sister cultures, n = 3–6. The results of the paired t-test on two popu-
lations (mock vs. mean): *p < 0.05.
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on the ability of media to activate microglia, suggesting
that putative soluble mediators are heat-resistant low-
molecular weight factors. Possible candidates could
include "gliotransmitters" such as ATP [47]. These mole-
cules secreted by neurons and astrocytes work as media-
tors of cell-to-cell communication in a physiological
condition, and may serve as "warning molecules" in path-
ological conditions [22,48]. We found no significant
effects of BDV infection on production of ATP. In addi-
tion, the ATP concentrations in the media was very low (<
10 nM) compared to concentrations of 0.1–10 mM that
have been found to activate neurons and microglia in
vitro [33-36]. Noteworthy, ATP in culture media is typi-
cally associated with release of intracellular ATP from
lysed cells. Thus, our findings are consistent with the lack
of BDV-associated cell toxicity in vitro. Future studies may
help to identify if other nucleotides mediate microglia
activation.
Our data provide more insights into the possible sequence
of events leading to neurodegeneration in neonatally
BDV-infected rats. Primary BDV infection of neurons may
produce activation of astrocytes and ensuing activation of
microglia. It remains unresolved whether microglia acti-
vation initiates cell demise or simply exacerbates on-going
cell injury. A recent report by Solbrig et al [49] lends an
additional support for the first hypothesis. Specifically,
the authors have shown that inhibition of microglia acti-
vation with a cannabinoid agonist decreases cell death in
the BDV-infected rat brain [48]. In a broader context, our
report is in line with an emerging idea that chronic activa-
tion of the innate immune system in the brain contributes
to neuronal injury even if a pathogen may not be directly
toxic to neurons.
Conclusion
The present study demonstrates that astrocytes play a key
role in activating microglia by BDV infection. We report
that BDV-infected neurons activate uninfected astrocytes
as evidenced by expression of RANTES, and activated
astrocytes in turn stimulate microglia. Our study indicates
that viral proteins could be responsible for activation of
uninfected astrocytes that may secrete heat-resistant low
molecular weight factors to activate microglia in mixed
cultures.
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